These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22785035)

  • 1. Role of secretory phospholipase A(2) in rhythmic contraction of pulmonary arteries of rats with monocrotaline-induced pulmonary arterial hypertension.
    Tanabe Y; Saito-Tanji M; Morikawa Y; Kamataki A; Sawai T; Nakayama K
    J Pharmacol Sci; 2012; 119(3):271-81. PubMed ID: 22785035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of untransformed prostaglandin H(2) production and stretch-induced contraction of rabbit pulmonary arteries by indoxam, a selective secretory phospholipase A(2) inhibitor.
    Tanabe Y; Saito M; Morikawa Y; Kamataki A; Sawai T; Hirose M; Nakayama K
    J Pharmacol Sci; 2011; 115(4):525-31. PubMed ID: 21422723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhythmical contractions in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats.
    Kiyoshi A; Ishikawa T; Hayashi K; Iwatsuki Y; Ishii K; Nakayama K
    Pflugers Arch; 2003 Nov; 447(2):142-9. PubMed ID: 14517679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
    Dhein S; Giessler C; Heinroth-Hoffmann I; Leineweber K; Seyfarth T; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):87-95. PubMed ID: 11819025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
    Ozturk EI; Uma S
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High magnesium mitigates the vasoconstriction mediated by different types of calcium influx from monocrotaline-induced pulmonary hypertensive rats.
    Zhuang XL; Zhu ZL; Huang QH; Yan FR; Zheng SY; Lai SM; Jiao HX; Lin MJ
    Exp Physiol; 2022 Apr; 107(4):359-373. PubMed ID: 35193162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2(+)-induced contraction and hyperreactivity of pulmonary arterial smooth muscle in monocrotaline-treated rats.
    Takenaka T; Ogawa Y; Tobise K
    Jpn Circ J; 1990 May; 54(5):515-23. PubMed ID: 2122039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
    BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
    Horstman DJ; Frank DU; Rich GF
    Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
    Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats.
    Wang HL; Dong X; Zhang XH; Xing J
    Acta Pharmacol Sin; 2001 Mar; 22(3):269-73. PubMed ID: 11742576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
    Nakazawa H; Hori M; Ozaki H; Karaki H
    Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.